Jack Routes, MD, explores the link between primary immunodeficiency and autoimmune disorders in this informative webinar. Routes will discuss the correlation, symptoms, and management of these conditions. Hosted…
Thomas Fox, MBChB, MD, PhD, dives into the complexities of treating primary immunodeficiencies with bone marrow transplants, highlighting the necessity for highly individualized patient assessments. He introduces two…
A recent study published in Lancet Neurology reveals important associations between MSH3 gene mutations and Huntington’s disease progression and disease burden.
Current therapeutic options for non-small cell lung cancer (NSCLC) are ever-evolving with the possibility of solely immunotherapy-based treatment regimens on the near horizon for certain patients.
Nicotinamide riboside appears to be the best precursor supplement available to help maintain or increase NAD+ levels. All cells and tissues can use it, and at high doses…
